← Leaderboards
Alan I Green
Harvard University (Medical School)
$33,040,263
Attributed
$34,642,867
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.3M · FY2005–18$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$34,642,867 · 14
By mechanism
UL1$18,335,787 · 1
R01$10,990,437 · 6
KL2$3,271,893 · 1
R21$1,833,211 · 4
R03$158,000 · 1
R13$53,539 · 1
Top collaborators
- John N Clore1 shared
Others in their field
Top investigators on “Schizophrenia”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$104,668,216
- Raquel E Gur · University Of Pennsylvania$60,189,770
- Mark J Daly · Broad Institute, Inc.$48,989,393
- John M Kane · Long Island Jewish Medical Center$45,235,871
- Carrie E Bearden · University Of California Los Angeles$42,025,230
- Scott W Woods · Yale University$41,221,536
Research focus
SchizophreniaClozapineClinical ResearchCannabisComorbidityFundingTranslational ResearchResearch PersonnelBaseBrainRisperidonePharmaceutical PreparationsDesignGeneral PopulationProgramsReward CircuitryRewardsAtypical AntipsychoticAntipsychotic AgentsInvestigationBiologyClinical TrialsBasic ScienceBiological Sciences
Grant awards (46)
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?$658,535
R01 · FY2018 · DA · contact PI
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?$234,680
R01 · FY2018 · DA · contact PI
Reward circuit dysfunction, substance use disorder and schizophrenia: a preclinical fMRI-based connectivity study$29,218
R21 · FY2018 · DA · contact PI
SYNERGY: The Dartmouth Center for clinical and Translational Science$2,196,551
UL1 · FY2017 · TR · contact PI
SYNERGY: The Dartmouth Center for clinical and Translational Science$668,584
KL2 · FY2017 · TR · contact PI
Clozapine for Cannabis Use Disorder in Schizophrenia$471,047
R01 · FY2017 · DA · contact PI
Reward circuit dysfunction, substance use disorder and schizophrenia: a preclinical fMRI-based connectivity study$283,500
R21 · FY2017 · DA · contact PI
SYNERGY: The Dartmouth Center for clinical and Translational Science$3,191,503
UL1 · FY2016 · TR · contact PI
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?$917,202
R01 · FY2016 · DA · contact PI
SYNERGY: The Dartmouth Center for clinical and Translational Science$668,584
KL2 · FY2016 · TR · contact PI
Clozapine for Cannabis Use Disorder in Schizophrenia$1
R01 · FY2016 · DA · contact PI
SYNERGY: The Dartmouth Center for clinical and Translational Science$4,432,320
UL1 · FY2015 · TR · contact PI
SYNERGY: The Dartmouth Center for clinical and Translational Science$1,071,136
KL2 · FY2015 · TR · contact PI
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?$918,493
R01 · FY2015 · DA · contact PI
Clozapine for Cannabis Use Disorder in Schizophrenia$877,797
R01 · FY2015 · DA · contact PI
SYNERGY: The Dartmouth Center for clinical and Translational Science$3,205,208
UL1 · FY2014 · TR · contact PI
SYNERGY: The Dartmouth Center for clinical and Translational Science$3,191,933
UL1 · FY2014 · TR · contact PI
SYNERGY: The Dartmouth Center for clinical and Translational Science$668,584
KL2 · FY2014 · TR · contact PI
SYNERGY: The Dartmouth Center for clinical and Translational Science$68,098
UL1 · FY2014 · TR · contact PI
SYNERGY: The Dartmouth Center for clinical and Translational Science$2,050,174
UL1 · FY2013 · TR · contact PI
Clozapine for Cannabis Use Disorder in Schizophrenia$878,495
R01 · FY2013 · DA · contact PI
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?$834,904
R01 · FY2013 · DA · contact PI
SYNERGY: The Dartmouth Center for clinical and Translational Science$195,005
KL2 · FY2013 · TR · contact PI
Clozapine for Cannabis Use Disorder in Schizophrenia$972,030
R01 · FY2012 · DA · contact PI
Alcoholism and Schizophrenia: A Translational Approach to Treatment$181,606
R21 · FY2012 · AA · contact PI
Deconstructing Clozapine: Toward Medication for Alcoholism in Schizophrenia$324,622
R01 · FY2011 · AA · contact PI
Alcoholism and Schizophrenia: A Translational Approach to Treatment$233,855
R21 · FY2011 · AA · contact PI
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment?$694,875
R01 · FY2010 · DA · contact PI
Deconstructing Clozapine: Toward Medication for Alcoholism in Schizophrenia$375,250
R01 · FY2010 · AA · contact PI
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment?$383,123
R01 · FY2009 · DA · contact PI
Toward Optimal Treatment for Schizophrenia and Co-Occurring Alcohol Use Disorder:$53,539
R13 · FY2009 · AA · contact PI
CANNABIS AND SCHIZOPHRENIA: CLOZAPINE VS RISPERIDONE$395,000
R01 · FY2005 · DA
Cannabis &Schizophrenia: fMRI Reward Circuit Biomaker$199,875
R21 · FY2005 · DA
Antipsychotics and Alcohol Drinking in Rodents$79,000
R03 · FY2005 · AA
CANNABIS AND SCHIZOPHRENIA: CLOZAPINE VS RISPERIDONE$395,000
R01 · FY2004 · DA
Cannabis &Schizophrenia: fMRI Reward Circuit Biomarker$234,645
R21 · FY2004 · DA
Antipsychotics and Alcohol Drinking in Rodents$79,000
R03 · FY2004 · AA
CANNABIS AND SCHIZOPHRENIA: CLOZAPINE VS RISPERIDONE$373,698
R01 · FY2003 · DA
Clozapine, cannabis and first episode schizophrenia$240,512
R21 · FY2003 · MH
Clozapine, cannabis and first episode schizophrenia$215,000
R21 · FY2002 · MH
CANNABIS AND SCHIZOPHRENIA: CLOZAPINE VS RISPERIDONE$56,302
R01 · FY2002 · DA
CANNABIS AND SCHIZOPHRENIA: CLOZAPINE VS RISPERIDONE$4,734
R01 · FY2002 · DA
ALCOHOLISM AND SCHIZOPHRENIA--EFFECTS OF CLOZAPINE$429,708
R01 · FY2001 · AA
Clozapine, cannabis and first episode schizophrenia$215,000
R21 · FY2001 · MH
CANNABIS AND SCHIZOPHRENIA: CLOZAPINE VS RISPERIDONE$430,000
R01 · FY2000 · DA
ALCOHOLISM AND SCHIZOPHRENIA--EFFECTS OF CLOZAPINE$364,941
R01 · FY2000 · AA